Women's Use of Vaginal Ring is Higher in Open-label Study, as is Level of HIV Protection
By EurekAlert!
Midway into a study in which all participants are offered use of a monthly vaginal ring containing an antiretroviral (ARV) drug called dapivirine, researchers have seen women's risk of acquiring HIV reduced by more than half.